At Axion BioSystems we understand the need to explore life’s circuitry. Many neurological disorders are highly debilitating, and the current treatment options are limited to symptom reduction rather than providing a cure. Advances in differentiating iPSCs towards a variety of neural cell types have recently unveiled promising opportunities to understand neurological diseases using patient cells.
This latest edition of Cell Press Selections features a collection of recent reviews and research articles that provide insight into how disease models can be used to gain deeper insight into disease mechanisms and for drug screening to identify effective therapeutics.
Request your free copy here.